<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250315065087N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-04-23</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Comparison of the Effectiveness of Positive Psychotherapy with Acceptance and Commitment Therapy in Women with Body Dysmorphia</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the Effectiveness of Positive Psychotherapy with Acceptance and Commitment Therapy on Experiential Avoidance, Self-Compassion, Emotion Regulation and Body Image of Women with Body Dysmorphia</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-04-19</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/82716</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The process of random allocation of participants to three groups of interventions and control includes both creating a random sequence and concealing the random allocation. Firstly, using the random sequence rule, 60 papers for participants of the interventions and control groups (which will be marked with A, B, and C and will not be defined to avoid bias) will be thrown into a lottery container and then the papers will be removed from the lottery container - without replacement - and the created sequence will be recorded. Then, using the snooze method, 60 envelopes will be prepared and each of the random sequences created will be recorded on a card and will be placed in the envelopes in order, and the envelopes will be also numbered. Then, the envelopes will be given to the participants based on the order of entering the study, so the grouping of each will be determined.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Body Dysmorphic Disorder.</hc_freetext>
      <i_freetext>Intervention 1: "Intervention group 1":  20 women with body dysmorphic disorder will participate in this group. This group will receive the acceptance and commitment intervention in 8 sessions, each lasting 90 minutes. inrevention is carried out in group setting. This intervention is based on the Eifert and Forsythe protocol. The interval between sessions is one week. The intervention period lasts two months. The content of this approach is as follows. First session: Establishing a therapeutic relationship, introducing individuals to the research topic; Second session: Discussion about experiences and their evaluation, efficiency as a measurement criterion, creating creative frustration; Third session: Expressing control as a problem, introducing desire as another response, engaging in purposeful actions; Fourth session: Using the technique of cognitive distancing, interfering with the functioning of problematic language chains, weakening one's alliance with thoughts and emotions; Fifth session: Observing the Self as Context, Undermining the Self as Self-Concept, and Expressing the Self as Observer; Sixth session: Application of mindfulness techniques, modeling of going out of mind, learning to see experiences as a process; Seventh session: Accepting yourself as an observer, accepting emotions instead of avoiding them; Eighth session 8: Discussion and review of previous sessions. Intervention 2: "Intervention group 2": 20 women with body dysmorphic disorder will participate in this group. This group will receive positive psychology intervention. The intervention consists of 8 sessions and every session lasts 90 minutes. inrevention is carried out in group setting. The interval between sessions is one week. The intervention period lasts two months. The content of this approach is as follows. First session: Getting to know each other and building rapport, not blaming or judging, clarifying the assumptions and roles of positive psychotherapy, presenting the assignment; Second session: Reviewing the previous session's practice, expressing and introducing yourself positively; Third session: Review of the previous session, planning and implementing the client's capabilities, sense of commitment, relationship between capabilities used and emotions experienced, providing taste techniques to improve positive emotions and experience a sense of hope, optimism, and focus; Fourth session: Presenting the assignment from the previous session, implementing help the client understand the role of past memories (good or bad), the role and focus on these memories as they lead to symptoms of the disorder, presenting the assignment; Fifth session: Reviewing the previous session's exercise, implementing and designing the forgiveness structure as a tool to eliminate anger and bitterness of negative emotions, the forgiveness technique for writing letters as a tool to eliminate errors, implementing the sugar-making technique to increase the level of happiness in oneself; Sixth session: Reviewing the assignments from the previous session, paying attention to good or bad memories, and exploring strategies to reduce signs of physical deformity, paying attention to signs of gratitude to increase the individual's self-esteem and self-confidence; Seventh session: Review of the previous session's assignment, client's feedback on the positive energy process; Eighth session: Review of the previous session's exercise, discussion of the whole life approach, offering suggestions for new ideas for climbing and working, and providing exercises and activities, reviewing unreviewed techniques and achievements of the treatment process. Intervention 3: "Control group": 20 women with body dysmorphic disorder who will not receive any intervention.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is Not allowed by the university.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Samira Ahmadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Vali Abad Ave., Khalij Fars Blv., Tonekabon</address>
        <city>Tonekabon</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4684161167</zip>
        <telephone>+98 11 5427 1105</telephone>
        <email>Samira66ahmadi22@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Samira Ahmadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Vali Abad Ave, Khalij Fars Blv, Tonekabon</address>
        <city>Tonekabon</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4684161167</zip>
        <telephone>+98 11 5427 1105</telephone>
        <email>Samira66ahmadi22@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Being diagnosed with body dysmorphic disorder which will be assessed using 5th version of the structured clinical interview for diagnostic  and statistical manual of mental disorders (SCID-5)
Being a woman
Ability to read and write
Age between 18 and 45 years old</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>45 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Receiving simultaneous psychotherapy
Substance abuse</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F45.22</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Body dysmorphic disorder</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>"Intervention group 1":  20 women with body dysmorphic disorder will participate in this group. This group will receive the acceptance and commitment intervention in 8 sessions, each lasting 90 minutes. inrevention is carried out in group setting. This intervention is based on the Eifert and Forsythe protocol. The interval between sessions is one week. The intervention period lasts two months. The content of this approach is as follows. First session: Establishing a therapeutic relationship, introducing individuals to the research topic; Second session: Discussion about experiences and their evaluation, efficiency as a measurement criterion, creating creative frustration; Third session: Expressing control as a problem, introducing desire as another response, engaging in purposeful actions; Fourth session: Using the technique of cognitive distancing, interfering with the functioning of problematic language chains, weakening one's alliance with thoughts and emotions; Fifth session: Observing the Self as Context, Undermining the Self as Self-Concept, and Expressing the Self as Observer; Sixth session: Application of mindfulness techniques, modeling of going out of mind, learning to see experiences as a process; Seventh session: Accepting yourself as an observer, accepting emotions instead of avoiding them; Eighth session 8: Discussion and review of previous sessions</i_keyword>
      <i_keyword>"Intervention group 2": 20 women with body dysmorphic disorder will participate in this group. This group will receive positive psychology intervention. The intervention consists of 8 sessions and every session lasts 90 minutes. inrevention is carried out in group setting. The interval between sessions is one week. The intervention period lasts two months. The content of this approach is as follows. First session: Getting to know each other and building rapport, not blaming or judging, clarifying the assumptions and roles of positive psychotherapy, presenting the assignment; Second session: Reviewing the previous session's practice, expressing and introducing yourself positively; Third session: Review of the previous session, planning and implementing the client's capabilities, sense of commitment, relationship between capabilities used and emotions experienced, providing taste techniques to improve positive emotions and experience a sense of hope, optimism, and focus; Fourth session: Presenting the assignment from the previous session, implementing help the client understand the role of past memories (good or bad), the role and focus on these memories as they lead to symptoms of the disorder, presenting the assignment; Fifth session: Reviewing the previous session's exercise, implementing and designing the forgiveness structure as a tool to eliminate anger and bitterness of negative emotions, the forgiveness technique for writing letters as a tool to eliminate errors, implementing the sugar-making technique to increase the level of happiness in oneself; Sixth session: Reviewing the assignments from the previous session, paying attention to good or bad memories, and exploring strategies to reduce signs of physical deformity, paying attention to signs of gratitude to increase the individual's self-esteem and self-confidence; Seventh session: Review of the previous session's assignment, client's feedback on the positive energy process; Eighth session: Review of the previous session's exercise, discussion of the whole life approach, offering suggestions for new ideas for climbing and working, and providing exercises and activities, reviewing unreviewed techniques and achievements of the treatment process.</i_keyword>
      <i_keyword>"Control group": 20 women with body dysmorphic disorder who will not receive any intervention</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Body image score in Body Image Scale. Timepoint: Before intervention (pre-test), after intervention (post-test), 3 months after intervention (follow-up). Method of measurement: Body Image Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Self-Compassion score in Self-Compassion Scale. Timepoint: Before intervention (pre-test), after intervention (post-test), 3 month after intervention (follow-up). Method of measurement: Self-Compassion Scale.</sec_outcome>
      <sec_outcome>Difficulty in emotion regulation score in Difficulty in Emotion Regulation Scale. Timepoint: Before intervention (pre-test), after intervention (post-test), 3 month after intervention (follow-up). Method of measurement: Difficulty in Emotion Regulation Scale.</sec_outcome>
      <sec_outcome>Acceptance and action score in Acceptance and Action Scale. Timepoint: Before intervention (pre-test), after intervention (post-test), 3 month after intervention (follow-up). Method of measurement: Acceptance and Action Scale.</sec_outcome>
      <sec_outcome>Experiential avoidance score in Experiential Avoidance Scale. Timepoint: Before intervention (pre-test), after intervention (post-test), 3 month after intervention (follow-up). Method of measurement: Experiential Avoidance Scale.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-12-18</approval_date>
        <contact_name>Ethics committee of Islamic Azad University-Tonekabon Branch</contact_name>
        <contact_address>Vali Abad Ave, Khalij Fars Blv, Tonekabon Tonekabon Mazandaran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
